Stumpf, Janina
Al-Sawaf, Othman
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Accepted: 5 December 2023
First Online: 4 January 2024
Declarations
:
: O.A.S.: Advisory Board (Ascentage, AstraZeneca, AbbVie, BeiGene, Eli Lilly, Gilead, Janssen, Roche), speaker honoraria (Adaptive, AstraZeneca, AbbVie, BeiGene, Eli Lilly, Gilead, Janssen, Roche), research funding (BeiGene, AbbVie, Janssen, Roche) J.S.: No competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.